Abstract Body

Globally, there were 5.7 million [4.7 million– 6.6 million] people living with HIV (PLHIV) 50 years of age and older (50+) in 2016. Although the proportion of PLHIV50+ was greater in high-income countries, low- and middle-income countries have higher numbers of PLHIV50+ that are expected to continue to increase by 2020. The proportion of PLHIV50+ across the world increased substantially from 8% in 2000 to 16% in 2016 and is expected to increase to 21% by 2020*. In the United States, it is estimated that more than 70% of PLHIV will be 50 or older in 2020.

Thirty-nine years into the epidemic, we’ve seen a remarkable shift in the trajectory of HIV. No longer is an HIV diagnosis simply a death sentence, individuals with HIV are living longer than ever before. Issues related to aging, long ignored due largely to irrelevance, are coming to the fore. What does it mean to age with HIV across the lifespan? How do co-morbidities, polypharmacy, long-term adherence to medications, mental health, neurocognitive impairment, stigma, discrimination, and fatigue factor into long-term survival? How do resilience and other mechanisms shift the narrative from surviving to thriving? What factors must be considered beyond viral suppression when assessing the quality of life? Each panelist will share their distinctive perspectives and experiences and will then open up the discussion to include audience members.

* Global and regional trends of people living with HIV aged 50 and over: Estimates and projections for 2000–2020, PLoS One. 2018; 13(11): e0207005.